Literature DB >> 16133967

The role of the tumor necrosis factor receptor in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice.

Minoru Nakai1, Kaori Sudo, Yasuhiro Yamada, Yasushi Kojima, Tomohiro Kato, Kuniaki Saito, Hisataka Moriwaki, Mitsuru Seishima.   

Abstract

We investigated the effect of TNBS administration using TNF-receptor knockout mice to elucidate the role of TNF receptors in chronic inflammation of the colon. Histologically, inflammatory cell scores showed no significant differences among TNBS-administered groups, while tissue damage scores were significantly lower in TNFR-1KO and TNFR-1,2KO than in WT. The apoptotic indexes of lamina propria mononuclear cells (LPMC) of all TNBS-administered groups were significantly lower than that of controls. TNF-alpha mRNA expression in the colon was significantly higher in all TNBS-administered groups than in controls. And NF-kappa B activities were enhanced in WT and TNFR-2KO compared with controls. Our data indicate that the TNF/TNFR-1 signaling system mediates mucosal damage through the enhancement of NF-kappa B activity and that continuous infiltration of TNF-producing cells, probably a key pathogeneses of colitis, may be closely associated with defective apoptosis of LPMC, which is possibly independent of the TNF/TNFR signaling system in TNBS-induced colitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133967     DOI: 10.1007/s10620-005-2913-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

Review 1.  Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.

Authors:  W J Sandborn; S B Hanauer
Journal:  Inflamm Bowel Dis       Date:  1999-05       Impact factor: 5.325

2.  Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis.

Authors:  H Marzo-Ortega; D McGonagle; P O'Connor; P Emery
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

3.  Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha.

Authors:  P E Watkins; B F Warren; S Stephens; P Ward; R Foulkes
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

4.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.

Authors:  Y Yamada; I Kirillova; J J Peschon; N Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

5.  A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.

Authors:  S E Plevy; C J Landers; J Prehn; N M Carramanzana; R L Deem; D Shealy; S R Targan
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

6.  Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.

Authors:  T T MacDonald; P Hutchings; M Y Choy; S Murch; A Cooke
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

7.  Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production.

Authors:  B Siegmund; G Fantuzzi; F Rieder; F Gamboni-Robertson; H A Lehr; G Hartmann; C A Dinarello; S Endres; A Eigler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-10       Impact factor: 3.619

8.  Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis.

Authors:  M Boirivant; M Marini; G Di Felice; A M Pronio; C Montesani; R Tersigni; W Strober
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

9.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

Authors:  F Powrie; M W Leach; S Mauze; S Menon; L B Caddle; R L Coffman
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

10.  Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa.

Authors:  G Rogler; K Brand; D Vogl; S Page; R Hofmeister; T Andus; R Knuechel; P A Baeuerle; J Schölmerich; V Gross
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

View more
  9 in total

1.  Resveratrol suppresses colitis and colon cancer associated with colitis.

Authors:  Xiangli Cui; Yu Jin; Anne B Hofseth; Edsel Pena; Joshua Habiger; Alexander Chumanevich; Deepak Poudyal; Mitzi Nagarkatti; Prakash S Nagarkatti; Udai P Singh; Lorne J Hofseth
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-23

2.  Moxibustion inhibits apoptosis and tumor necrosis factor-alpha/tumor necrosis factor receptor 1 in the colonic epithelium of Crohn's disease model rats.

Authors:  Chun-Hui Bao; Lu-Yi Wu; Huan-Gan Wu; Yin Shi; Hui-Rong Liu; Rong Zhang; Li-Qing Yu; Jin-Hai Wang
Journal:  Dig Dis Sci       Date:  2012-04-25       Impact factor: 3.199

3.  Colitogenic role of tumour necrosis factor (TNF) receptors in trinitrobenzene sulphonic acid colitis: TNF-R1 ablation does not affect systemic inflammatory response.

Authors:  Y Yang; H Wang; Y Dou; Y Wang; G Han; Renxi Wang; L Wang; R Guo; H Xiao; X Li; B Shen; Y Shi; G Chen; Y Li
Journal:  Clin Exp Immunol       Date:  2011-06-14       Impact factor: 4.330

4.  Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis.

Authors:  Shivesh Punit; Philip E Dubé; Cambrian Y Liu; Nandini Girish; M Kay Washington; D Brent Polk
Journal:  Gastroenterology       Date:  2015-06-11       Impact factor: 22.682

Review 5.  Redeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel disease.

Authors:  Philip E Dubé; Shivesh Punit; D Brent Polk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-04       Impact factor: 4.052

6.  Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation.

Authors:  Kiarash Riazi; Michael A Galic; J Brent Kuzmiski; Winnie Ho; Keith A Sharkey; Quentin J Pittman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-27       Impact factor: 11.205

7.  Opposite role of tumor necrosis factor receptors in dextran sulfate sodium-induced colitis in mice.

Authors:  Ke Wang; Gencheng Han; Yan Dou; Yi Wang; Guijun Liu; Renxi Wang; He Xiao; Xinying Li; Chunmei Hou; Beifen Shen; Renfeng Guo; Yan Li; Yanchun Shi; Guojiang Chen
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

8.  TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis.

Authors:  Xin Chen; Yingjie Nie; Haitao Xiao; Zhaoxiang Bian; Anthony J Scarzello; Na-Young Song; Anna L Trivett; Joost J Oppenheim
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

9.  The Proteolytic Fraction From Vasconcellea cundinamarcensis Latex Displays Anti-Inflammatory Effect in A Mouse Model of Acute TNBS-Induced Colitis.

Authors:  Ronniel Morais Albuquerque; Marina Passos Pizzitola; Ana Cândida Araújo E Silva; Dalton Dittz; Kátia Michelle Freitas; Ênio Ferreira; Carlos Edmundo Salas; Miriam Teresa Paz Lopes
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.